- Published at
- by manilatimes.net
neutral
neutral
News for Knight Therapeutics Inc. (GUD.TO)
- Published at
- by gurufocus.com
neutralneutral60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Raised approximately $2.118 million in gross proceeds since the beginning of 2025 WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals,- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
neutralneutral- Published at
- by financialpost.com
positivepositiveKnight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®
MONTREAL and LUGANO, Switzerland, Jan. 28, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutica…- Published at
- by gurufocus.com
neutralneutralSixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
WASHINGTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. ( SXTP; SXTPW) (”60 Degrees” or the ”Company”), pharmaceutical company,- Published at
- by manilatimes.net
mixedmixed- Published at
- by financialpost.com
positivepositiveKnight Therapeutics Announces Regulatory Approval of TAVALISSE® in Mexico
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced tod…- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
mixedmixed60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma- Published at
- by manilatimes.net
mixedmixed- Published at
- by financialpost.com
mixedmixedKnight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico
MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced tod…- Published at
- by globenewswire.com
positivepositiveCutaneous and Systemic Leishmaniasis Market Projected to Expand to $487.5 Million by 2034 | Fact.MR
Greater Access to Healthcare in Developing Countries Driving Demand for Cutaneous and Systemic Leishmaniasis Treatment: Fact.MR Report...- Published at
- by stockspinoffinvesting.com
mixedmixedBuy Medexus Pharma
Buy Medexus Pharma (MEDXF) Market Cap: $34MM Price: $1.38 Price Target: $4+ Upside: 189%+ Summary Medexus Pharma (MEDXF) truly represents an asymmetric opportunity. The stock trades at 2x FCF and 5.2x EBITDA. Does the company have a lot of debt? No! Its net debt to EBITDA is currently 2.2x and will be 1.5x by the end of the year. Does the- Published at
- by etfdailynews.com
mixedmixed- Published at
- by gurufocus.com
mixedmixedMawer New Canada Fund Buys goeasy, Parkland Corp, Andlauer Healthcare Group Inc, Sells FirstService Corp, Kinaxis Inc, Absolute Software Corp
GuruFocus Article or News written by GuruFocusNews and the topic is about:- Published at
- by markets.businessinsider.com
mixedmixedKnight Therapeutics Announces Canadian Commercial Launch of IBSRELA™ - New Innovative Treatment for Irritable Bowel Syndrome with Constipation
MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), (“Knight”) a pan-American (ex-USA) specialty pharmaceutical co...- Published at
- by marketwatch.com
mixedmixedJaguar Health shares soar 40% in heavy volume, on track for 18-month high
Shares of Jaguar Health Inc., a developer of plant-based medicines for people and animals, soared more than 40% on Tuesday in heavy volume, extending their...